Advances in therapy

Keyphrases

Publications

volume 41, number 9, 2024

Antti Aarni Mäkitie, Rasheed Omobolaji Alabi, Laura Pulkki-Råback, Alhadi Almangush, Jonathan J Beitler, Nabil F Saba, Primož Strojan, Robert Takes, Orlando Guntinas-Lichius, Alfio Ferlito
Psychological Factors Related to Treatment Outcomes in Head and Neck Cancer. Advances in therapy 41 (9) (2024)
Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Motohiro Tamiya, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Koutaro Yokote, Riku Ota, Shogo Wada, Hiroyuki Matsuda, Ronald Filomeno
Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment Comparison. Advances in therapy 41 (9) (2024)
Yasuhiro Gon, Ryoko Sorimachi, Yuri Yoshida, Yoichi Tamai, Ikumi Takashima, Yoshifumi Arita, Hisatoshi Sugiura
Real-World Treatment Patterns and Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease in Japan: The REMIND Study. Advances in therapy 41 (9) (2024)
Claire N Harrison, Alessandro M Vannucchi, Christian Recher, Francesco Passamonti, Aaron T Gerds, Juan Carlos Hernandez-Boluda, Abdulraheem Yacoub, Shireen Sirhan, Catherine Ellis, Bharat Patel, Bryan Strouse, Uwe Platzbecker
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2. Advances in therapy 41 (9) (2024)
Yasuhiro Gon, Ryoko Sorimachi, Yuri Yoshida, Yoichi Tamai, Ikumi Takashima, Yoshifumi Arita, Hisatoshi Sugiura
Real-World Treatment Patterns and Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease in Japan: The REMIND Study. Advances in therapy 41 (9) (2024)
Guoying Cao, Haijing Yang, Jingjing Wang, Masahiro Ishida, Christian Thoma, Thomas Haeufel, Sebastian Bossert, Wanzhen Li
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study. Advances in therapy 41 (9) (2024)
Katherine L Gooch, Ivana Audhya, Kristen Ricchetti-Masterson, Shelagh M Szabo
Current Challenges of Using Patient-Level Claims and Electronic Health Record Data for the Longitudinal Evaluation of Duchenne Muscular Dystrophy Outcomes. Advances in therapy 41 (9) (2024)
Joseph V Pergolizzi, Amanjot Batra, William K Schmidt
A Novel Formulation of Ketorolac Tromethamine (NTM-001) in Continuous Infusion in Adults with and without Renal Impairment: A Randomized Controlled Pharmacologic Study. Advances in therapy 41 (9) (2024)
Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M Turner, Janvi Sah
Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in therapy 41 (9) (2024)
Jun Gong, Melissa A Reimers
A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape. Advances in therapy 41 (9) (2024)
Yasuhiro Gon, Ryoko Sorimachi, Yuri Yoshida, Yoichi Tamai, Ikumi Takashima, Yoshifumi Arita, Hisatoshi Sugiura
Real-World Treatment Patterns and Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease in Japan: The REMIND Study. Advances in therapy 41 (9) (2024)
Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Guoying Cao, Haijing Yang, Jingjing Wang, Masahiro Ishida, Christian Thoma, Thomas Haeufel, Sebastian Bossert, Wanzhen Li
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study. Advances in therapy 41 (9) (2024)
Joseph V Pergolizzi, Amanjot Batra, William K Schmidt
A Novel Formulation of Ketorolac Tromethamine (NTM-001) in Continuous Infusion in Adults with and without Renal Impairment: A Randomized Controlled Pharmacologic Study. Advances in therapy 41 (9) (2024)
Katherine L Gooch, Ivana Audhya, Kristen Ricchetti-Masterson, Shelagh M Szabo
Current Challenges of Using Patient-Level Claims and Electronic Health Record Data for the Longitudinal Evaluation of Duchenne Muscular Dystrophy Outcomes. Advances in therapy 41 (9) (2024)
Jun Gong, Melissa A Reimers
A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape. Advances in therapy 41 (9) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Tobias J Lange, Pilar Escribano-Subias, Audrey Muller, Catarina C Fernandes, Martina Fontana, Tatiana Remenova, Stefan Söderberg, Sean Gaine
Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study). Advances in therapy 41 (9) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M Turner, Janvi Sah
Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in therapy 41 (9) (2024)
Antti Aarni Mäkitie, Rasheed Omobolaji Alabi, Laura Pulkki-Råback, Alhadi Almangush, Jonathan J Beitler, Nabil F Saba, Primož Strojan, Robert Takes, Orlando Guntinas-Lichius, Alfio Ferlito
Psychological Factors Related to Treatment Outcomes in Head and Neck Cancer. Advances in therapy 41 (9) (2024)
Koutaro Yokote, Riku Ota, Shogo Wada, Hiroyuki Matsuda, Ronald Filomeno
Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment Comparison. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Katherine L Gooch, Ivana Audhya, Kristen Ricchetti-Masterson, Shelagh M Szabo
Current Challenges of Using Patient-Level Claims and Electronic Health Record Data for the Longitudinal Evaluation of Duchenne Muscular Dystrophy Outcomes. Advances in therapy 41 (9) (2024)
Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Joseph V Pergolizzi, Amanjot Batra, William K Schmidt
A Novel Formulation of Ketorolac Tromethamine (NTM-001) in Continuous Infusion in Adults with and without Renal Impairment: A Randomized Controlled Pharmacologic Study. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Tobias J Lange, Pilar Escribano-Subias, Audrey Muller, Catarina C Fernandes, Martina Fontana, Tatiana Remenova, Stefan Söderberg, Sean Gaine
Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study). Advances in therapy 41 (9) (2024)
Motohiro Tamiya, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Jun Gong, Melissa A Reimers
A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape. Advances in therapy 41 (9) (2024)
Roberto Caporali, Aditi Kadakia, Oliver Howell, Jayesh Patel, Jack Milligan, Sander Strengholt, Sophie Barlow, Peter C Taylor
A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor Inhibitor. Advances in therapy 41 (9) (2024)
Fernando Gomez-Peralta, Isabel Leiva Gea, Natalia Duque, Esther Artime, Miriam Rubio-de Santos
Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review. Advances in therapy 41 (9) (2024)
Tobias J Lange, Pilar Escribano-Subias, Audrey Muller, Catarina C Fernandes, Martina Fontana, Tatiana Remenova, Stefan Söderberg, Sean Gaine
Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study). Advances in therapy 41 (9) (2024)
Yan Liang, Xiaobo Chen, Rongxiu Zheng, Xinran Cheng, Zhe Su, Xiumin Wang, Hongwei Du, Min Zhu, Guimei Li, Yan Zhong, Shengquan Cheng, Baosheng Yu, Yu Yang, Ruimin Chen, Lanwei Cui, Hui Yao, Qiang Gu, Chunxiu Gong, Zhang Jun, Xiaoyan Huang, Deyun Liu, Xueqin Yan, Haiyan Wei, Yuwen Li, Huifeng Zhang, Yanjie Liu, Fengyun Wang, Gaixiu Zhang, Xin Fan, Hongmei Dai, Xiaoping Luo
Validation of an AI-Powered Automated X-ray Bone Age Analyzer in Chinese Children and Adolescents: A Comparison with the Tanner-Whitehouse 3 Method. Advances in therapy 41 (9) (2024)
Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M Turner, Janvi Sah
Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in therapy 41 (9) (2024)
Fernando Gomez-Peralta, Isabel Leiva Gea, Natalia Duque, Esther Artime, Miriam Rubio-de Santos
Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review. Advances in therapy 41 (9) (2024)
Koutaro Yokote, Riku Ota, Shogo Wada, Hiroyuki Matsuda, Ronald Filomeno
Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment Comparison. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Claire N Harrison, Alessandro M Vannucchi, Christian Recher, Francesco Passamonti, Aaron T Gerds, Juan Carlos Hernandez-Boluda, Abdulraheem Yacoub, Shireen Sirhan, Catherine Ellis, Bharat Patel, Bryan Strouse, Uwe Platzbecker
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2. Advances in therapy 41 (9) (2024)
Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panes
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease. Advances in therapy 41 (9) (2024)
Yan Liang, Xiaobo Chen, Rongxiu Zheng, Xinran Cheng, Zhe Su, Xiumin Wang, Hongwei Du, Min Zhu, Guimei Li, Yan Zhong, Shengquan Cheng, Baosheng Yu, Yu Yang, Ruimin Chen, Lanwei Cui, Hui Yao, Qiang Gu, Chunxiu Gong, Zhang Jun, Xiaoyan Huang, Deyun Liu, Xueqin Yan, Haiyan Wei, Yuwen Li, Huifeng Zhang, Yanjie Liu, Fengyun Wang, Gaixiu Zhang, Xin Fan, Hongmei Dai, Xiaoping Luo
Validation of an AI-Powered Automated X-ray Bone Age Analyzer in Chinese Children and Adolescents: A Comparison with the Tanner-Whitehouse 3 Method. Advances in therapy 41 (9) (2024)
Fernando Gomez-Peralta, Isabel Leiva Gea, Natalia Duque, Esther Artime, Miriam Rubio-de Santos
Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review. Advances in therapy 41 (9) (2024)
Antti Aarni Mäkitie, Rasheed Omobolaji Alabi, Laura Pulkki-Råback, Alhadi Almangush, Jonathan J Beitler, Nabil F Saba, Primož Strojan, Robert Takes, Orlando Guntinas-Lichius, Alfio Ferlito
Psychological Factors Related to Treatment Outcomes in Head and Neck Cancer. Advances in therapy 41 (9) (2024)
Roberto Caporali, Aditi Kadakia, Oliver Howell, Jayesh Patel, Jack Milligan, Sander Strengholt, Sophie Barlow, Peter C Taylor
A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor Inhibitor. Advances in therapy 41 (9) (2024)
Roberto Caporali, Aditi Kadakia, Oliver Howell, Jayesh Patel, Jack Milligan, Sander Strengholt, Sophie Barlow, Peter C Taylor
A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor Inhibitor. Advances in therapy 41 (9) (2024)
Guoying Cao, Haijing Yang, Jingjing Wang, Masahiro Ishida, Christian Thoma, Thomas Haeufel, Sebastian Bossert, Wanzhen Li
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study. Advances in therapy 41 (9) (2024)
Motohiro Tamiya, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba
A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese Patients. Advances in therapy 41 (9) (2024)
Claire N Harrison, Alessandro M Vannucchi, Christian Recher, Francesco Passamonti, Aaron T Gerds, Juan Carlos Hernandez-Boluda, Abdulraheem Yacoub, Shireen Sirhan, Catherine Ellis, Bharat Patel, Bryan Strouse, Uwe Platzbecker
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2. Advances in therapy 41 (9) (2024)